Autoantibody-Targeted Treatments for Acute Exacerbations of Idiopathic Pulmonary Fibrosis.

Autoantibody-Targeted Treatments for Acute Exacerbations of Idiopathic Pulmonary Fibrosis.

Severe acute exacerbations (AE) of idiopathic pulmonary fibrosis (IPF) are medically untreatable and often fatal within days. Recent evidence suggests autoantibodies may be involved in IPF progression. Autoantibody-mediated lung diseases are typically refractory to glucocorticoids and nonspecific me...

Full description

Bibliographic Details
Main Authors: Michael Donahoe, Vincent G Valentine, Nydia Chien, Kevin F Gibson, Jay S Raval, Melissa Saul, Jianmin Xue, Yingze Zhang, Steven R Duncan
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4470587?pdf=render

Internet

http://europepmc.org/articles/PMC4470587?pdf=render

Similar Items